|
Market Closed -
Deutsche Boerse AG
10:20:38 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 149.80 EUR | +1.97% |
|
-3.17% | +26.20% |
| 09-25 | US FDA approves Mirum's drug for rare bone disorder | RE |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 33.6x | 21.36x | 0.63x | 12.18x | 24.75x | 26.19x | 0.59% | 1,053B | ||
| 30.11x | - | -1.63x | 6.7x | 18.74x | 21.06x | 1.98% | 652B | ||
| 33.53x | -482.8x | 0.14x | 7.84x | 16.21x | 16.89x | 2.59% | 468B | ||
| 19.76x | 7.23x | 1.35x | 4.82x | 11.93x | 13.23x | 2.75% | 351B | ||
| 20.25x | 5.76x | -11.68x | 5.27x | 13.08x | 13.95x | 3.03% | 273B | ||
| 20.9x | 4.71x | 1.05x | 4.34x | 12.34x | 12.99x | 2.04% | 254B | ||
| 25.65x | 19.4x | 2.28x | 6.7x | 11.94x | 15.39x | 2.48% | 220B | ||
| -45.27x | 11.15x | 0.3x | 6.59x | 25.75x | 62.46x | 2.2% | 186B | ||
| 11.33x | 4.78x | -3.77x | 4.13x | 8.58x | 10.04x | 4.44% | 170B | ||
| 17.92x | 1.85x | 1.08x | 3.36x | 8.62x | 9.8x | 6.06% | 162B | ||
| 53.69x | 8.48x | -1.47x | 9.67x | 33.16x | 26.69x | -.--% | 132B | ||
| 10.95x | 5.16x | 0.18x | 3.1x | 8.06x | 8.68x | 4.11% | 126B | ||
| 14.57x | 4.64x | -1.68x | 2.84x | 8.41x | 9.35x | 3.71% | 99.42B | ||
| 11.48x | 1.17x | -6.08x | 2.05x | 6.64x | 7.35x | 5.9% | 98.2B | ||
| 21.62x | 4.87x | 1.3x | 7.23x | 13.71x | 14.39x | 2.05% | 68.82B | ||
| 46.6x | 1.26x | 13.22x | 2.83x | 10.36x | 28.3x | 3.47% | 59.11B | ||
| 22.34x | 1.72x | -0.14x | 1.71x | 8.08x | 13.86x | 0.32% | 55.15B | ||
| 32.22x | 4.35x | 1.79x | 7.51x | 25.45x | 28.47x | 0.54% | 43.99B | ||
| Average | 21.18x | -22.05x | -0.17x | 5.49x | 14.77x | 18.84x | 2.68% | 248.44B | |
| Weighted average by Cap. | 24.27x | -49.19x | -0.60x | 7.22x | 17.23x | 20.17x | 2.23% |
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
- Sector Ipsen
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















